华绿生物
(300970)
| 流通市值：21.80亿 | | | 总市值：28.18亿 |
| 流通股本：1.24亿 | | | 总股本：1.60亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 693,881,412.3 | 414,243,699.16 | 1,291,890,340.95 | 867,669,135 |
| 营业总成本 | 636,029,193.71 | 297,997,767.92 | 1,179,931,454.88 | 858,235,706.04 |
| 其他经营收益 | | | | |
| 营业利润 | 55,616,262.89 | 119,243,097.68 | 123,860,193.54 | 16,943,532.89 |
| 利润总额 | 55,758,629.61 | 119,271,715.09 | 119,305,079.01 | 16,852,425.69 |
| 净利润 | 55,798,995.69 | 119,271,715.09 | 119,255,767.97 | 16,843,870.49 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 55,798,995.69 | 119,271,715.09 | 119,255,767.97 | 16,843,870.49 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 858,450,447.63 | 954,141,417.89 | 834,643,803.14 | 715,801,386.9 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,737,472,085.83 | 1,591,816,654.19 | 1,634,626,917.93 | 1,640,930,690.43 |
| 资产总计 | 2,595,922,533.46 | 2,545,958,072.08 | 2,469,270,721.07 | 2,356,732,077.33 |
| 流动负债: | | | | |
| 流动负债合计 | 203,951,986.66 | 230,754,539.36 | 245,198,206.92 | 182,884,229.74 |
| 非流动负债: | | | | |
| 非流动负债合计 | 715,996,664.44 | 525,795,017.96 | 552,196,863.98 | 616,681,283.26 |
| 负债合计 | 919,948,651.1 | 756,549,557.32 | 797,395,070.9 | 799,565,513 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,629,697,544.11 | 1,744,853,581.28 | 1,636,902,541.67 | 1,530,286,947.58 |
| 股东权益合计 | 1,675,973,882.36 | 1,789,408,514.76 | 1,671,875,650.17 | 1,557,166,564.33 |
| 负债和股东权益合计 | 2,595,922,533.46 | 2,545,958,072.08 | 2,469,270,721.07 | 2,356,732,077.33 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 712,506,494.78 | 418,607,128.22 | 1,327,094,393.76 | 885,329,372.68 |
| 经营活动现金流出小计 | 547,136,535.72 | 272,367,194.89 | 981,786,751.21 | 719,578,467.88 |
| 经营活动产生的现金流量净额 | 165,369,959.06 | 146,239,933.33 | 345,307,642.55 | 165,750,904.8 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 210,284,902.31 | 32,000 | 89,470.72 | 16,255,390.72 |
| 投资活动现金流出小计 | 260,345,890.55 | 35,007,721.26 | 123,118,056.12 | 82,112,396.36 |
| 投资活动产生的现金流量净额 | -50,060,988.24 | -34,975,721.26 | -123,028,585.4 | -65,857,005.64 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 11,170,000 | 8,670,000 | 175,231,119.89 | 144,541,531.89 |
| 筹资活动现金流出小计 | 127,084,253.3 | 15,014,483.49 | 168,454,416.01 | 128,524,601.44 |
| 筹资活动产生的现金流量净额 | -115,914,253.3 | -6,344,483.49 | 6,776,703.88 | 16,016,930.45 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -605,282.48 | 104,919,728.58 | 229,055,761.03 | 115,910,829.61 |
| 期末现金及现金等价物余额 | 588,033,164.55 | 693,558,175.61 | 588,638,447.03 | 475,493,515.61 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -605,282.48 | - | 229,055,761.03 | - |